Drugs / R-mabHDI
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00816959 Comparator | Jul 2011 → Apr 2014 | Hodgkins lymphoma | American Scitech International | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R-mabHDI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00816959 ↗ |
| Route | Intravenous | “R-mabHDI intravenously” NCT00816959 ↗ |